As per the USFDA#39;s Orange Book contains that data of all approved drugs in US, the patents of Imbruvica will start expiry only from 2026, some patents are valid all the way till 2033-2034.from Moneycontrol Business News http://bit.ly/2ToZSur
Thursday, January 31, 2019
Natco braces for major patent battle in US, submits ANDA of cancer drug Imbruvica
As per the USFDA#39;s Orange Book contains that data of all approved drugs in US, the patents of Imbruvica will start expiry only from 2026, some patents are valid all the way till 2033-2034.from Moneycontrol Business News http://bit.ly/2ToZSur
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment